Misconceptions and Facts About Hypertrophic Cardiomyopathy - 15/01/16
, Mark V. Sherrid, MD b, Franz H. Messerli, MD aAbstract |
Hypertrophic cardiomyopathy is the most common genetic heart disease. Once considered relentless, untreatable, and deadly, it has become a highly treatable disease with contemporary management. Hypertrophic cardiomyopathy is one of cardiology's “great masqueraders.” Mistakes and delays in diagnosis abound. Hypertrophic cardiomyopathy commonly “masquerades” as asthma, anxiety, mitral prolapse, and coronary artery disease. However, once properly diagnosed, patients with hypertrophic cardiomyopathy can be effectively managed to improve both symptoms and survival. This review highlights some of the misconceptions about hypertrophic cardiomyopathy. Providers at all levels should have awareness of hypertrophic cardiomyopathy to promptly diagnose and properly manage these individuals.
El texto completo de este artículo está disponible en PDF.Keywords : Echocardiography, Hypertrophic cardiomyopathy, Septal reduction therapy
Esquema
| Funding: None. |
|
| Conflict of Interest: EA: None; MVS: None; FHM: consultant or advisory relationships with the following companies: Daiichi-Sankyo, Pfizer, Abbott, Servier, Medtronic, WebMD, IPCA, ACC, Menarini, Relypsa. |
|
| Authorship: The work presented here is original and has not been submitted for publication elsewhere. The authors accept responsibility for the scientific content of the manuscript. |
Vol 129 - N° 2
P. 148-152 - février 2016 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?
